Literature DB >> 15727676

The use of 1% pimecrolimus cream for the treatment of steroid-induced rosacea.

C-Y Chu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15727676     DOI： 10.1111/j.1365-2133.2005.06404.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  5 in total

1.  [Steroid-aggravated rosacea: successful therapy with pimecrolimus].

Authors:  N Meykadeh; F Meiss; W C Marsch; M Fischer
Journal:  Hautarzt       Date:  2007-04       Impact factor: 0.751

Review 2.  [Rosacea. Clinical features, pathogenesis and therapy].

Authors:  P Lehmann
Journal:  Hautarzt       Date:  2005-09       Impact factor: 0.751

Review 3.  Interventions for rosacea.

Authors:  Esther J van Zuuren; Zbys Fedorowicz; Ben Carter; Mireille M D van der Linden; Lyn Charland
Journal:  Cochrane Database Syst Rev       Date:  2015-04-28

Review 4.  The US FDA 'black box' warning for topical calcineurin inhibitors: an ongoing controversy.

Authors:  Johannes Ring; Matthias Möhrenschlager; Verena Henkel
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

5.  [Topical therapy of rosacea].

Authors:  H Schöfer
Journal:  Hautarzt       Date:  2013-07       Impact factor: 0.751
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.